688331 RemeGen Co., Ltd.
- 44.53
- -0.66-1.46%
RemeGen Co., Ltd. News
Notice of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on convening the 2024 First Extraordinary General Meeting of Shareholders
Notice of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on convening the 2023 Annual General Meeting of Shareholders
Rongchang Biotech's announcement on the completion of some fund-raising special account sales
Announcement of Resolutions of the 13th Meeting of the 2nd Board of Directors of Rongchang Biotech
Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2023 Environmental, Social and Governance Report
Announcement of Resolutions of the 10th Meeting of the 2nd Board of Supervisors of Rongchang Biotech
Rongchang Biotech's announcement on adjusting the 2024-2025 daily related transaction forecast
Huatai United Securities Co., Ltd.'s verification opinion on Rongchang Biopharmaceutical (Yantai) Co., Ltd.'s adjustment of the 2024-2025 daily related transaction forecast
Rongchang Biotech's announcement on the completion of some fund-raising projects and permanently supplementing working capital with savings raised
Huatai United Securities Co., Ltd.'s verification opinion on the completion of some fund-raising projects of Rongchang Biopharmaceutical (Yantai) Co., Ltd. and the savings raised to permanently supplement working capital
Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2024 First Quarter Report
Huatai United Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Rongchang Biopharmaceuticals (Yantai) Co., Ltd.
Rongchang Biotech: Investor Relations Activity Record Form for April 15, 2024
Huatai United Securities Co., Ltd. report on the 2023 continuous supervision site inspection report of Rongchang Biopharmaceuticals (Yantai) Co., Ltd.
Announcement of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on participating in the 2023 Special Group Performance Briefing on Biological Products
Rongchang Biotech's indicative announcement on the 2024 plan to issue A-shares to specific targets
Announcement of Rongchang Biotech on the issuance of A shares to specific targets in 2024, diluted immediate returns and compensation measures and commitments from related entities
Feasibility analysis report on the use of funds raised by Rongchang Biotech by issuing A-shares to specific targets in 2024
Announcement of Resolutions of the 9th Meeting of the 2nd Board of Supervisors of Rongchang Biotech
Explanation of Rongchang Biotech's fund-raising investment in the field of scientific and technological innovation
Analysis
Price Target
No Data
